Current status of continuous subcutaneous insulin infusion and continuous XXXX monitoring systems in the Community of Madrid.

@entity1 @entity413 @entity6
OBJECTIVE: To analyze the available information about continuous subcutaneous insulin infusion (CSII) and continuous @entity413 monitoring (CGM) systems in the public health care system of the Community of Madrid. MATERIAL AND METHODS: A survey consisting of 31 items was sent to the 28 endocrinology department of the Madrid public hospitals. Items focused on CSII and CGM and included @entity1 ' registrations, as well as data regarding healthcare, administrative, and logistic aspects. Responses from a total of 20 hospitals where these procedures are used were received from March 2013 to May 2014. Data about pediatric @entity1 were obtained from adult endocrinology departments, except for two hospitals which directly reported the information. RESULTS: A total of 1256 CSII pumps were recorded in the Madrid region, of which 1089 were used by adults, and the remaining 167 by pediatric @entity1 . During 2013, 151 new CSII systems were implanted (12% of the total), while 14 pumps were withdrawn. Availability of @entity1 resources (medical assistance) and the number of staff practitioners experienced in management of these systems widely varied between hospitals. Eighty-five percent of hospitals used retrospective CGM systems, and 40% routinely placed them before starting an insulin pump. Thirteen hospitals (65%) used long-term, real-time CGM systems in selected cases (a total of 67 @entity1 ). CONCLUSIONS: Use of these technologies in @entity6 is unequal between public health care hospitals in Madrid, and is still significantly lower as compared to other countries with similar incomes. However, there appears to be a trend to an increase in their use.
